期刊论文

Wu, Y.-L.

中文

中国中药杂志

1001-5302

2007

32

18

1928-1931

10.3321/j.issn:1001-5302.2007.18.027

国家“十五”科技攻关项目（2001BA701A06）

本校为其他机构

目的：评价超微粉碎工艺的通心络胶囊治疗中风病（气虚血瘀络阻型）的临床疗效和安全性。方法：采用随机、双盲、不同工艺不同剂量平行对照的非劣效性试验设计方法，选择病程在2周以上3个月以内、神经功能缺损评分为8—30分、总的生活能力评分在2—5级的中风病恢复期患者144例，其中试验组72例，对照组72例。试验组服用超微粉碎工艺的通心络胶囊，规格每粒0．26g，1次4粒，1日3次；对照组服用普通粉碎工艺的通心络胶囊，规格每粒0．38g，1次4粒，1日3次；疗程28d。结果：中风病综合疗效，试验组与对照组总有效率分别为91．3％和87．3％，两组比较差异无统计学意义。两组总有效率差值的95％可信区...

Objective： To evaluate the clinical efficacy and security of super crush-run tong xinluo capsule （SCTXLC） for apoplexy due to energy-deficiency and blood-stasis. Method：The randomised controlled double blind non-inferiority trial versus paroxefine, parallel contrast, different Kinds of Techniques and dosage , the clinical trial design was adopted, 144 patients with stroke of convalescent stage were selected by 2 group, which course of diseases was in 2 weekens to 3 months, neurological deficit scores was 8 to 30, grade of acaties of daily l...